MS

Mirza Shabbir Ahmad

Active Director Director DIN 10202577
DIN 10202577 First appointment Jun 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mirza Shabbir Ahmad

Data last updated:

Mirza Shabbir Ahmad is a Director at Alstem Biotech Private Limited (since 2023). The company operates in Paper.

DIN 10202577
Primary Designation Director
Industry Paper
First Appointment 14 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alstem Biotech Private Limited U21001UP2023PTC184015
Director14 Jun 20232023Active

Board colleagues of Mirza Shabbir Ahmad

NameDINCompanyDesignation
Musrrat Jahan10202575Alstem Biotech Private LimitedDirector
Saba Khan10202576Alstem Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alstem Biotech Private Limited
Premium access

Shareholding and investment profile for Mirza Shabbir Ahmad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mirza Shabbir Ahmad

Mirza Shabbir Ahmad currently holds 1 directorship: Alstem Biotech Private Limited (Director, since 14 Jun 2023).

Mirza Shabbir Ahmad was first appointed on 14 Jun 2023 as Director at Alstem Biotech Private Limited.

The current boards of Mirza Shabbir Ahmad's companies include Musrrat Jahan (Alstem Biotech Private Limited), Saba Khan (Alstem Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available